Get the Stockscreener App
71.14
0.32%
-0.23
Henry Schein Inc stock is traded at $71.14, with a volume of 845.26K.
It is down -0.32% in the last 24 hours and up +3.64% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
See More
Previous Close:
$71.37
Open:
$71.41
24h Volume:
845.26K
Relative Volume:
0.57
Market Cap:
$8.80B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
29.16
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
+1.07%
1M Performance:
+3.64%
6M Performance:
-7.43%
1Y Performance:
+6.96%
1-Day Range:
$70.73
$72.71
1-Week Range:
$69.62
$72.71
52-Week Range:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
71.14 | 8.80B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
717.76 | 88.68B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
286.64 | 56.02B | 310.23B | 1.69B | 3.58B | 8.62 |
|
CAH
Cardinal Health Inc
|
153.53 | 36.77B | 222.29B | 1.56B | 2.44B | 6.41 |
|
AHG
Akso Health Group Adr
|
1.36 | 578.29M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Here's Why Henry Schein (HSIC) is a Strong Growth Stock - Yahoo Finance
Henry Schein, Inc. (NASDAQ:HSIC) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Henry Schein (HSIC) Updates Credit Agreements to Enhance Financi - GuruFocus
Henry Schein Selects IFS Cloud to Modernize Dental Field Service Operations - Orthodontic Products
KKR is Now a Partial Owner of Henry Schein - Medical Product Outsourcing
Henry Schein Amends $750M Term Loan Agreement - TipRanks
Wellington Management Group LLP Boosts Holdings in Henry Schein, Inc. (NASDAQ:HSIC) - Defense World
Henry Schein, Inc. (NASDAQ:HSIC) Short Interest Up 19.6% in May - Defense World
Henry Schein Optimizes Services Using IFS - Dentistry Today
Henry Schein at Jefferies Global Healthcare: Strategic Growth Focus - Investing.com
Transcript : Henry Schein, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 12 - marketscreener.com
Henry Schein Opts for IFS to Optimize Field Service and Streamline Global Operations - Automation.com
Henry Schein (HSIC) Up 6.5% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Updated: Henry Schein to Participate in Upcoming Investor Conference in June | HSIC Stock News - GuruFocus
Updated: Henry Schein to Participate in Upcoming Investor Conference in June - Business Wire
Henry Schein at Stifel Jaws & Paws: Strategic Growth Insights - Investing.com
Transcript : Henry Schein, Inc. Presents at Stifel Jaws & Paws Conference 2025, May-29-2025 12 - marketscreener.com
Henry Schein, Inc. (NASDAQ:HSIC) Q1 2025 Earnings Call Transcript - MSN
How AI helps Henry Schein One's accounts payable team - TechTarget
Should You Retain Henry Schein Stock in Your Portfolio Right Now? - MSN
Henry Schein Faces Dental Market Setback, But Holds Firm On Profit Forecasts - Finimize
Henry Schein Inc (HSIC) Stock Price Up 3.31% on May 27 - GuruFocus
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term - Yahoo Finance
Saudi Arabia Dental Implants Market Trends and Forecasts 2020-2024 & 2025-2030, Competitive Analysis of Masar Medical, Keydent, Zimmer Biomet, Dentsply Sirona, and Henry Schein - Yahoo
Ameriprise Financial Inc. Lowers Stake in Henry Schein, Inc. (NASDAQ:HSIC) - Defense World
Henry Schein: Is The Continued Growth in Home Solutions Expected To Last? - Smartkarma
Henry Schein shareholders approve executive pay, elect directors By Investing.com - Investing.com South Africa
Are Wall Street Analysts Predicting Henry Schein Stock Will Climb or Sink? - MSN
Henry Schein, Inc. (HSIC) Announces Key Decisions from 2025 Annu - GuruFocus
Henry Schein Approves Key Proposals at Annual Meeting - TipRanks
Henry Schein shareholders approve executive pay, elect directors - Investing.com
On Our Island: Long Island honors heroes, celebrates culture and tech - Long Island Business News
Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors - Zenopa
Captrust Financial Advisors Lowers Position in Henry Schein, Inc. (NASDAQ:HSIC) - Defense World
KKR completes $250M Henry Schein investment, cements major shareholder status - Oral Health Group
Henry Schein One Unveils The Catalyst Index - Dentistry Today
Henry Schein One Unveils The Catalyst Index, a Look into Dentist - GuruFocus
Henry Schein One Unveils The Catalyst Index, a Look into Dentistry's Top 10% | HSIC Stock News - GuruFocus
Henry Schein One Unveils The Catalyst Index, a Look into Dentistry’s Top 10% - The Joplin Globe
Are Wall Street Analysts Predicting Henry Schein Stock Will Climb Or Sink? - Barchart.com
Henry Schein completes investment, names new board members - HME News
Henry Schein Stock Post Earnings Review (NASDAQ:HSIC) - Seeking Alpha
Henry Schein (HSIC) Completes $250 Million Private Placement wit - GuruFocus
Henry Schein secures $250 million investment from KKR By Investing.com - Investing.com South Africa
Henry Schein Finalizes $250 Million KKR Investment, Expands Board Leadership - Orthodontic Products
Henry Schein Announces Completion of Strategic Investment by KKR - GuruFocus
Henry Schein Completes $250M Deal with KKR - TipRanks
KKR Closes $250 Million Investment in Henry Schein - marketscreener.com
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
3.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):